Overview Effect of Exenatide on Cortisol Secretion Status: Completed Trial end date: 2017-12-28 Target enrollment: Participant gender: Summary The primary aim of the study is to describe the effect of single dose of 10 micrograms (μg) exenatide given subcutaneously (s/c) on cortisol secretion. Secondary outcomes involve ACTH and glucose levels. Phase: Phase 4 Details Lead Sponsor: University of TartuTreatments: ExenatideHydrocortisone